Dr. Jeffrey Everett Taber, MD

Dr. Taber practices at Rio Grande Urology PA in El Paso, Texas.

Dr. Taber's NPI, 1861448987, was assigned on May 26, 2006. Dr. Taber graduated from Duke University School Of Medicine in 1992. Dr. Taber holds Texas license K4260.

Dr. Taber's primary practice is Rio Grande Urology PA, at 2201 N Stanton St, El Paso, TX 79902 in El Paso County. The practice phone is (915) 532-8823.

Dr. Taber's primary practice is Rio Grande Urology PA in El Paso, Texas. Dr. Taber is also affiliated with University Medical Center of El Paso. The medical group on file is Rio Grande Urology. Dmand AI also links Dr. Taber to 4 more hospitals, 2 group practices and clinics, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Taber practices, 8 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Taber's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Taber is board certified in urology by the American Board of Urology. Dmand AI has Dr. Taber's licenses on file in 4 states: Texas, Florida, North Carolina and New Mexico.

Dmand AI lists bladder disease, bladder removal, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery and kidney stone disease among the conditions Dr. Taber treats.

CMS data shows 2,253 Medicare services from Dr. Taber across 17 procedure codes in 2024, for 795 Medicare patients. Medicare paid $113,766 for them.

CMS counts 795 Medicare patients who saw Dr. Taber in 2024. The largest group is 75 to 84, with 337 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.24, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Taber's median patient age at 72, with 16% women.

In 2024, Dr. Taber wrote 4,902 Medicare Part D claims for 1,320 patients. 94% of them were for generic drugs. CMS names the drug for 4,736 of them, across 38 drugs with 11 or more claims each, at $244,939 in total drug cost. In 2023, CMS named 4,290 claims across 42 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Taber for performance year 2024, reported as part of a group. Dr. Taber accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Taber. The most frequent topics are Electroencephalography and Epilepsy. Dr. Taber has published most often in Clin Electroencephalogr. Dr. Taber's most frequent co-author is Jesse E. Taber, MD.

CMS Open Payments shows 264 general payments to Dr. Taber from 44 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 81% of the total. NeoTract Inc. paid the most, $2,922.

Dmand AI lists 3 awards for Dr. Taber, most recently CMS Stage 1 2012 in 2012.

Dr. Taber graduated from Duke University School Of Medicine in 1992. Dr. Taber is a member of ACS.

Dr. Taber is in network with 21 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.